Cavernous sinus thrombosis diagnostic study of choice: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Cavernous sinus thrombosis}} {{CMG}}; {{AE}} {{MMJ}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *The incidence/prevalence of [disease name] i...")
 
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Cavernous sinus thrombosis}}
{{Cavernous sinus thrombosis}}
{{CMG}}; {{AE}} {{MMJ}}
{{CMG}}; {{AE}} {{MMJ}}
==Overview==
== Overview ==
 
==Epidemiology and Demographics==
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].
 
===Race===
*There is no racial predilection to [disease name].
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.


===Region===
[[Magnetic resonance imaging]] (MRI) with [[Venography|MR venography]] is the gold standard test for the diagnosis of cavernous sinus thrombosis. The following findings on performing [[MRI]] are confirmatory for cavernous sinus thrombosis: Absent flow void in '''T1''' and '''T2''' and signal characteristics vary depending on the age of the [[thrombus]] but will be abnormal. Contrast-enhancement or lack of is not a reliable indicator as organising [[thrombus]] can enhance. Diagnosis can generally be made on [[venography]].
*The majority of [disease name] cases are reported in [geographical region].


*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
== Diagnostic Study of Choice ==


===Developed Countries===
=== Study of choice ===
[[Magnetic resonance imaging]] (MRI) with [[Venography|MR venography]] is the gold standard test for the diagnosis of cavernous sinus thrombosis.<ref name="pmid22368772">{{cite journal| author=Chiewvit P, Piyapittayanan S, Poungvarin N| title=Cerebral venous thrombosis: diagnosis dilemma. | journal=Neurol Int | year= 2011 | volume= 3 | issue= 3 | pages= e13 | pmid=22368772 | doi=10.4081/ni.2011.e13 | pmc=3286153 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22368772  }} </ref><ref name="pmid8570157">{{cite journal| author=Igarashi H, Igarashi S, Fujio N, Fukui K, Yoshida A| title=Magnetic resonance imaging in the early diagnosis of cavernous sinus thrombosis. | journal=Ophthalmologica | year= 1995 | volume= 209 | issue= 5 | pages= 292-6 | pmid=8570157 | doi=10.1159/000310635 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8570157  }} </ref><ref name="pmid8014656">{{cite journal| author=Berge J, Louail C, Caillé JM| title=Cavernous sinus thrombosis diagnostic approach. | journal=J Neuroradiol | year= 1994 | volume= 21 | issue= 2 | pages= 101-17 | pmid=8014656 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8014656  }} </ref>


===Developing Countries===
===== Diagnostic results =====
The following findings on performing [[MRI]] are confirmatory for cavernous sinus thrombosis:
* '''T1''' and '''T2'''
** Absent flow void
** Signal characteristics vary depending on the age of the [[thrombus]] but will be abnormal.
* Contrast-enhancement or lack of is not a reliable indicator as organising [[thrombus]] can enhance.
* Diagnosis can generally be made on [[venography]].


==References==
==References==

Latest revision as of 15:25, 2 July 2018

Cavernous sinus thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cavernous sinus thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cavernous sinus thrombosis diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cavernous sinus thrombosis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cavernous sinus thrombosis diagnostic study of choice

CDC on Cavernous sinus thrombosis diagnostic study of choice

Cavernous sinus thrombosis diagnostic study of choice in the news

Blogs on Cavernous sinus thrombosis diagnostic study of choice

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cavernous sinus thrombosis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Magnetic resonance imaging (MRI) with MR venography is the gold standard test for the diagnosis of cavernous sinus thrombosis. The following findings on performing MRI are confirmatory for cavernous sinus thrombosis: Absent flow void in T1 and T2 and signal characteristics vary depending on the age of the thrombus but will be abnormal. Contrast-enhancement or lack of is not a reliable indicator as organising thrombus can enhance. Diagnosis can generally be made on venography.

Diagnostic Study of Choice

Study of choice

Magnetic resonance imaging (MRI) with MR venography is the gold standard test for the diagnosis of cavernous sinus thrombosis.[1][2][3]

Diagnostic results

The following findings on performing MRI are confirmatory for cavernous sinus thrombosis:

  • T1 and T2
    • Absent flow void
    • Signal characteristics vary depending on the age of the thrombus but will be abnormal.
  • Contrast-enhancement or lack of is not a reliable indicator as organising thrombus can enhance.
  • Diagnosis can generally be made on venography.

References

  1. Chiewvit P, Piyapittayanan S, Poungvarin N (2011). "Cerebral venous thrombosis: diagnosis dilemma". Neurol Int. 3 (3): e13. doi:10.4081/ni.2011.e13. PMC 3286153. PMID 22368772.
  2. Igarashi H, Igarashi S, Fujio N, Fukui K, Yoshida A (1995). "Magnetic resonance imaging in the early diagnosis of cavernous sinus thrombosis". Ophthalmologica. 209 (5): 292–6. doi:10.1159/000310635. PMID 8570157.
  3. Berge J, Louail C, Caillé JM (1994). "Cavernous sinus thrombosis diagnostic approach". J Neuroradiol. 21 (2): 101–17. PMID 8014656.

Template:WH Template:WS